Protective effect of Euphorbia thymifolia and Euphorbia hirta against carbon tetrachloride-induced hepatotoxicity in Wistar rats. (3rd August 2022)
- Record Type:
- Journal Article
- Title:
- Protective effect of Euphorbia thymifolia and Euphorbia hirta against carbon tetrachloride-induced hepatotoxicity in Wistar rats. (3rd August 2022)
- Main Title:
- Protective effect of Euphorbia thymifolia and Euphorbia hirta against carbon tetrachloride-induced hepatotoxicity in Wistar rats
- Authors:
- Balasubramanian, Balamuralikrishnan
Liu, Wen-Chao
Arumugam, Vijaya Anand
Gurupalraj, Durai Muthu Mani
Ramasamy, Manikandan
Madhavan, Shenbagam
Velayuthaprabhu, Shanmugam
Park, Sungkwon - Abstract:
- Abstract: Objectives: The present study aims to investigate the protective effect of Euphorbia thymifolia and Euphorbia hirta extracts on in vitro antioxidant activity and in vivo analysis on hepatic marker enzyme levels and histopathological changes in the liver of carbon tetrachloride (CCl4 ) induced hepatotoxicity rats. Materials and methods: This study includes 42 adult male Albino Wistar rats randomly divided into seven treatment groups, including control (basal diet, G1), CCl4 -induced single dose (1.5 ml/kg, i.p.) as the negative control (G2), G1 supplemented with 300 mg/kg of ethanol extract of E. thymifolia (G3) and E. hirta (G4), G2 supplemented with 300 mg/kg of ethanol extract of E. thymifolia (G5), E. hirta (G6), and silymarin (25 mg/kg b.w.) used as a standard drug (G7) for 21-days experimental period. Results: The ethanolic extracts of E. thymifolia and E. hirta exhibited potential in vitro antioxidant activity in a dose-dependent manner (25 μg/ml, 50 μg/ml, 100 μg/ml, 200 μg/ml and 250 μg/ml). Oxidative stress caused by CCl4 -induced the liver damage, including changes in liver marker enzymes (aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase), enzymatic (superoxide dismutase and catalase), non-enzymatic antioxidants (lipid peroxides and glutathione) and hepatocellular alterations such as hydropic degeneration, irregular hepatocytes, and distention of the vein. Administration of E. thymifolia and E. hirta significantly ( pAbstract: Objectives: The present study aims to investigate the protective effect of Euphorbia thymifolia and Euphorbia hirta extracts on in vitro antioxidant activity and in vivo analysis on hepatic marker enzyme levels and histopathological changes in the liver of carbon tetrachloride (CCl4 ) induced hepatotoxicity rats. Materials and methods: This study includes 42 adult male Albino Wistar rats randomly divided into seven treatment groups, including control (basal diet, G1), CCl4 -induced single dose (1.5 ml/kg, i.p.) as the negative control (G2), G1 supplemented with 300 mg/kg of ethanol extract of E. thymifolia (G3) and E. hirta (G4), G2 supplemented with 300 mg/kg of ethanol extract of E. thymifolia (G5), E. hirta (G6), and silymarin (25 mg/kg b.w.) used as a standard drug (G7) for 21-days experimental period. Results: The ethanolic extracts of E. thymifolia and E. hirta exhibited potential in vitro antioxidant activity in a dose-dependent manner (25 μg/ml, 50 μg/ml, 100 μg/ml, 200 μg/ml and 250 μg/ml). Oxidative stress caused by CCl4 -induced the liver damage, including changes in liver marker enzymes (aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase), enzymatic (superoxide dismutase and catalase), non-enzymatic antioxidants (lipid peroxides and glutathione) and hepatocellular alterations such as hydropic degeneration, irregular hepatocytes, and distention of the vein. Administration of E. thymifolia and E. hirta significantly ( p < 0.05) restored the enzyme activity along with the histology of the liver. Conclusion: The results from the current study demonstrate that E. thymifolia and E. hirta have the property of restoring hepatic redox capacity and antioxidant activities against CCl4 -induced acute liver damage. … (more)
- Is Part Of:
- Drug development and industrial pharmacy. Volume 48:Number 8(2022)
- Journal:
- Drug development and industrial pharmacy
- Issue:
- Volume 48:Number 8(2022)
- Issue Display:
- Volume 48, Issue 8 (2022)
- Year:
- 2022
- Volume:
- 48
- Issue:
- 8
- Issue Sort Value:
- 2022-0048-0008-0000
- Page Start:
- 406
- Page End:
- 416
- Publication Date:
- 2022-08-03
- Subjects:
- Superoxide dismutase -- catalase -- lipid peroxides -- aspartate aminotransferase -- alanine aminotransferase -- alkaline phosphatase
Pharmaceutical chemistry -- Periodicals
Pharmaceutical industry -- Periodicals
Drug Industry -- Periodicals
Technology, Pharmaceutical -- Periodicals
615.05 - Journal URLs:
- http://informahealthcare.com/loi/ddi ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/03639045.2022.2122985 ↗
- Languages:
- English
- ISSNs:
- 0363-9045
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.116000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24430.xml